An essay presented at the European Congress on Obesity in Istanbul, Turkey (12–15 May) suggests that a new age of obesity drugs could shift the blame for living with obesity from individuals to the food industry—just as smoking ...
May 10, 2026
0
5
A new analysis presented at the European Congress on Obesity (ECO 2026, Istanbul, Turkey, 12–15 May) examined daily oral orforglipron treatment for the treatment of obesity, with or without diabetes, in users aged 65 years ...
May 10, 2026
0
4
New research presented at the European Congress on Obesity (ECO 2026) in Istanbul, Turkey (12–15 May) and published in the International Journal of Environmental Research and Public Health shows that doing around 8,500 steps ...
May 9, 2026
0
8
New research presented at the European Congress on Obesity (ECO 2026, Istanbul, Turkey, 12–15 May) shows that, following treatment for obesity or diabetes or both, using incretin-based drugs, losing more weight versus less ...
May 9, 2026
0
6
A recent study in the Journal of Nutrition Education and Behavior examined the impact of the Healthy Steps to Freedom (HSF-10) program on nutrition, body image, and health-related behaviors among 607 women undergoing treatment ...
May 9, 2026
0
4
Starting in July, Medicare beneficiaries may be able to get a GLP-1 prescription for weight loss for $50 a month. It's a notable shift for Medicare, which has long been barred from covering weight loss treatments.
May 8, 2026
0
11
Changes in gut microbiota after bariatric surgery are strongly linked to altered metabolic health and sustained improvement in type 2 diabetes, according to a study led by researchers at the University of Gothenburg.
May 7, 2026
0
4
A study has found that an emerging class of GLP-1 weight-loss drugs suppresses eating for pleasure, or hedonic feeding, in mice by modulating a reward circuit deep within the brain. This newly charted pathway—separate from ...
May 6, 2026
0
11
Metabolic and bariatric surgery delivers significantly greater weight loss and higher rates of obesity-related disease remission than glucagon-like peptide-1 receptor agonists (GLP-1s), according to one of the largest and ...
May 6, 2026
0
6
Weight gain during menopause is common, with abdominal obesity being especially common and unhealthy. A new study based on data from the Study of Women's Health Across the Nation (SWAN) has found that in addition to its adverse ...
May 6, 2026
0
4
